Public Health and Social Services Emergency Fund
Schedules
TAFS: 075-0140 /X - Public Health and Social Services Emergency Fund
| Previously Approved (Iteration 1) | OMB Action (Iteration 2) | |||||
|---|---|---|---|---|---|---|
| Line # | Split | Description | Amount | Footnotes | Amount | Footnotes |
| 1000 | DA | Discretionary Actual Unob Bal: Brought forward, Oct 1 | Line added | $37,271,307,507.00 | ||
| 1000 | DE | Discretionary Estimated Unob Bal: Brought forward, Oct 1 | $84,622,148,188.00 | |||
| 1000 | MA | Mandatory Actual Unob Bal: Brought forward, Oct 1 | Line added | $44,891,965,374.00 | ||
| 1000 | ME | Mandatory Estimated Unob Bal: Brought forward, Oct 1 | $13,005,078.00 | |||
| 1021 | Unob Bal: Recov of prior year unpaid obligations | Line added | $849,167,002.00 | |||
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | Line added | $1,768,681,314.00 | |||
| 1100 | BA: Disc: Appropriation | Line added | $1,727,000,000.00 | |||
| 1134 | BA: Disc: Appropriations precluded from obligation | Line added | -$1,059,859,900.00 | See footnotes below | ||
| Footnotes for line 1134 (Current): | B1: Amount on line 1134 has been adjusted pursuant to OMB Bulletin 21-05. | |||||
| 1920 | Total budgetary resources avail (disc. and mand.) | $84,635,153,266.00 | $85,448,261,297.00 | |||
| 6001 | Category A -- 1st quarter | $17,242.00 | $17,242.00 | |||
| 6013 | Strategic National Stockpile | $186,883,798.00 | See footnotes below | $581,532,102.00 | See footnotes below | |
| Footnotes for line 6013 (Previous): | A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. | |||||
| Footnotes for line 6013 (Current): | A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2022 Carryover spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. | |||||
| 6015 | Pandemic Influenza (Vaccines, Antivirals & Diagnostics) | $1,372,597.00 | $16,214,257.00 | |||
| 6016 | Pandemic Influenza (Facilities, Vaccines, Antivirals, and Diagnostics) | $460,041.00 | $450,942.00 | |||
| 6017 | Pandemic Influenza (Other HHS Activities) | $4,573,608.00 | $5,998,720.00 | |||
| 6018 | Pandemic Influenza (Other CDC Activities) | $651,478.00 | $940,592.00 | |||
| 6019 | Parklawn Lease Replacement | $441,978.00 | $448,317.00 | |||
| 6021 | Haiti CDC | $7,508,952.00 | $2,523,377.00 | |||
| 6024 | HHS Lease Replacements | $1,183,003.00 | $1,183,003.00 | |||
| 6025 | Project BioShield | $850,059,794.00 | See footnotes below | $748,981,738.00 | See footnotes below | |
| Footnotes for line 6025 (Previous): | A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. | |||||
| Footnotes for line 6025 (Current): | A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2022 Carryover spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. | |||||
| 6026 | Pandemic Influenza | $97,940,017.00 | See footnotes below | $195,640,051.00 | See footnotes below | |
| Footnotes for line 6026 (Previous): | A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. | |||||
| Footnotes for line 6026 (Current): | A11: For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2022 Carryover spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. | |||||
| 6027 | NDMS | $69,924.00 | $69,927.00 | |||
| 6028 | Bioterrorism | $724,333.00 | $409,222.00 | |||
| 6029 | CDC Capacity | $74,317.00 | $303,431.00 | |||
| 6030 | Natural Disasters | $4,888,792.00 | $4,888,792.00 | |||
| 6032 | CDC Preparedness | $175,229.00 | $175,229.00 | |||
| 6036 | Pediatric Disaster Care | $13,005,078.00 | $13,005,078.00 | |||
| 6037 | Coronavirus 2 Testing for the Uninsured | $1,706,914.00 | See footnotes below | $1,703,282.00 | See footnotes below | |
| Footnotes for line 6037 (Previous): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. A6: Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| Footnotes for line 6037 (Current): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. A6: Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| 6038 | Coronavirus 3 Healthcare Provider Reimbursements | $2,500,578,549.00 | See footnotes below | $2,438,811,227.00 | See footnotes below | |
| Footnotes for line 6038 (Previous): | A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| Footnotes for line 6038 (Current): | A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the December 14, 2021 Provider Relief spend plan. $4,300,000,000 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year Provider Relief Fund obligations consistent with the aggregate limitations by line items in the December 14, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| 6039 | Coronavirus 4 Healthcare Provider Reimbursements | $33,189,785,643.00 | See footnotes below | $32,212,544,163.00 | See footnotes below | |
| Footnotes for line 6039 (Previous): | A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| Footnotes for line 6039 (Current): | A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the December 14, 2021 Provider Relief spend plan. $4,300,000,000 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year Provider Relief Fund obligations consistent with the aggregate limitations by line items in the December 14, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| 6040 | Coronavirus 4 Allocations to State, Local, Tribal and other entities | $257,172,556.00 | See footnotes below | $258,391,170.00 | See footnotes below | |
| Footnotes for line 6040 (Previous): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. | |||||
| Footnotes for line 6040 (Current): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. | |||||
| 6041 | Coronavirus 4 BARDA | $967,079.00 | See footnotes below | $1,835,365.00 | See footnotes below | |
| Footnotes for line 6041 (Previous): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. | |||||
| Footnotes for line 6041 (Current): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. | |||||
| 6042 | Coronavirus 4 Testing for Uninsured | $2,900.00 | See footnotes below | $3,435.00 | See footnotes below | |
| Footnotes for line 6042 (Previous): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. A6: Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| Footnotes for line 6042 (Current): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. A6: Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| 6043 | Coronavirus 4 Rural Health Clinics Testing | $3,214,991.00 | See footnotes below | $3,066,557.00 | See footnotes below | |
| Footnotes for line 6043 (Previous): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. | |||||
| Footnotes for line 6043 (Current): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. | |||||
| 6044 | Coronavirus 4 HHS Response Activities | $335,766,847.00 | See footnotes below | $323,145,844.00 | See footnotes below | |
| Footnotes for line 6044 (Previous): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. A7: Funds are available immediately for obligation consistent with the July 21, 2021 PPPHCEA Testing Spend Plan, and any updates to that plan. Within the total for the Testing Spend Plan, HHS may update this plan by increasing or decreasing any line by the lesser of $500,000 or 5%. HHS must notify OMB within five business days of any such change by providing an updated Testing Spend Plan and supporting rationale. | |||||
| Footnotes for line 6044 (Current): | A12: HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. A7: Funds are available immediately for obligation consistent with the July 21, 2021 PPPHCEA Testing Spend Plan, and any updates to that plan. Within the total for the Testing Spend Plan, HHS may update this plan by increasing or decreasing any line by the lesser of $500,000 or 5%. HHS must notify OMB within five business days of any such change by providing an updated Testing Spend Plan and supporting rationale. | |||||
| 6046 | Coronavirus 5 Healthcare Provider Reimbursements | $3,000,000,000.00 | See footnotes below | $3,000,000,000.00 | See footnotes below | |
| Footnotes for line 6046 (Previous): | A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| Footnotes for line 6046 (Current): | A10: Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the December 14, 2021 Provider Relief spend plan. $4,300,000,000 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year Provider Relief Fund obligations consistent with the aggregate limitations by line items in the December 14, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. A5: Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. | |||||
| 6047 | Coronavirus 6 Healthcare Provider Reimbursements | $8,500,000,000.00 | See footnotes below | $8,500,000,000.00 | See footnotes below | |
| Footnotes for line 6047 (Previous): | A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. | |||||
| Footnotes for line 6047 (Current): | A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. | |||||
| 6048 | Coronavirus 6 Testing, Contact Tracing, and Mitigation Activities | $25,098,883,573.00 | See footnotes below | $26,567,526,896.00 | See footnotes below | |
| Footnotes for line 6048 (Previous): | A13: Funds are available immediately for obligation consistent with the September 3, 2021, Section 2401 Testing Spend Plan. Funds are available for additional activities five business days after HHS provides OMB notification of spending plans. | |||||
| Footnotes for line 6048 (Current): | A13: Funds are available immediately for obligation consistent with the December 21, 2021, Section 2401 Testing Spend Plan. Funds are available for additional activities five business days after HHS provides OMB notification of spending plans. A15: Of the amounts apportioned on line 6048, up to 10% of the amounts already approved for projects on the December 21, 2021 Section 2401 Testing Spend Plan, may be used for COVID-19 testing and mitigation activities for individuals who arrive in the U.S. from Afghanistan. HHS shall notify OMB no later than five business days after such funds have been repurposed. | |||||
| 6049 | Coronavirus 6 Public Health Workforce | $4,908,255,785.00 | See footnotes below | $4,900,005,493.00 | See footnotes below | |
| Footnotes for line 6049 (Previous): | A9: Of this total, $740,755,785 is available immediately for obligation consistent with the previously approved Public Health Workforce FY 2021 spend plan. Funds are available for additional projects five business days after an HHS approved spend plan has been submitted to OMB. | |||||
| Footnotes for line 6049 (Current): | A9: Funds are available immediately for obligation consistent with the December 27, 2021 Public Health Workforce spend plan. Funds are available for additional projects five business days after an HHS approved spend plan has been submitted to OMB. | |||||
| 6050 | Coronavirus 6 Strategic National Stockpile | $850,000,000.00 | See footnotes below | $850,000,000.00 | See footnotes below | |
| Footnotes for line 6050 (Previous): | A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. | |||||
| Footnotes for line 6050 (Current): | A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. | |||||
| 6051 | Coronavirus 6 Antivirals | $3,118,578,248.00 | $3,118,244,051.00 | |||
| 6052 | Coronavirus 6 Vaccines, Therapeutics, and Medical Supplies | $1,602,710,000.00 | See footnotes below | $1,602,701,794.00 | See footnotes below | |
| Footnotes for line 6052 (Previous): | A14: Funds are available immediately for obligation consistent with the September 30, 2021 FY 22 Operation Spending Plan. HHS will promptly notify OMB of changes by the lesser of $10,000,000 or 10 percent in the cost of those contracts, IAAs, and IDDAs. Funds are available for additional projects five business days after HHS provides OMB notification of spending plans. | |||||
| Footnotes for line 6052 (Current): | A14: Funds are available immediately for obligation consistent with the December 17, 2021 FY 22 Operation Spending Plan. HHS will promptly notify OMB of changes by the lesser of $10,000,000 or 10 percent in the cost of those contracts, IAAs, and IDDAs. Funds are available for additional projects five business days after HHS provides OMB notification of spending plans. | |||||
| 6053 | Coronavirus 6 Medical Reserve Corps | $97,500,000.00 | See footnotes below | $97,500,000.00 | See footnotes below | |
| Footnotes for line 6053 (Previous): | A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. | |||||
| Footnotes for line 6053 (Current): | A8: Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. | |||||
| 6190 | Total budgetary resources available | $84,635,153,266.00 | See footnotes below | $85,448,261,297.00 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A2: Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments. A3: The multiple category B lines for Pandemic Influenza are used because some appropriations had more broad legal authorities than others. Obligations may be funded from multiple category B lines provided that the obligation is consistent with the purpose of the appropriation. A4: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available, plus the amount governed by footnote A10. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | |||||
| Footnotes for line 6190 (Current): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A16: Funds appropriated by PL 117-43 and extended by PL 117-70 were apportioned to this account by OMB Bulletin 21-05. In the event of an extension of that continuing resolution beyond February 18, 2021, the amounts apportioned to this account for related activities shall be increased by the amount that automatic apportionment would have increased in the absence of this written apportionment. A2: Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments. A3: The multiple category B lines for Pandemic Influenza are used because some appropriations had more broad legal authorities than others. Obligations may be funded from multiple category B lines provided that the obligation is consistent with the purpose of the appropriation. A4: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available, plus the amount governed by footnote A10. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | |||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A10 | Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the December 14, 2021 Provider Relief spend plan. $4,300,000,000 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year Provider Relief Fund obligations consistent with the aggregate limitations by line items in the December 14, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. |
| A11 | For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2022 Carryover spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. |
| A12 | HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. |
| A13 | Funds are available immediately for obligation consistent with the December 21, 2021, Section 2401 Testing Spend Plan. Funds are available for additional activities five business days after HHS provides OMB notification of spending plans. |
| A14 | Funds are available immediately for obligation consistent with the December 17, 2021 FY 22 Operation Spending Plan. HHS will promptly notify OMB of changes by the lesser of $10,000,000 or 10 percent in the cost of those contracts, IAAs, and IDDAs. Funds are available for additional projects five business days after HHS provides OMB notification of spending plans. |
| A15 | Of the amounts apportioned on line 6048, up to 10% of the amounts already approved for projects on the December 21, 2021 Section 2401 Testing Spend Plan, may be used for COVID-19 testing and mitigation activities for individuals who arrive in the U.S. from Afghanistan. HHS shall notify OMB no later than five business days after such funds have been repurposed. |
| A16 | Funds appropriated by PL 117-43 and extended by PL 117-70 were apportioned to this account by OMB Bulletin 21-05. In the event of an extension of that continuing resolution beyond February 18, 2021, the amounts apportioned to this account for related activities shall be increased by the amount that automatic apportionment would have increased in the absence of this written apportionment. |
| A2 | Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments. |
| A3 | The multiple category B lines for Pandemic Influenza are used because some appropriations had more broad legal authorities than others. Obligations may be funded from multiple category B lines provided that the obligation is consistent with the purpose of the appropriation. |
| A4 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available, plus the amount governed by footnote A10. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A5 | Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. |
| A6 | Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. |
| A7 | Funds are available immediately for obligation consistent with the July 21, 2021 PPPHCEA Testing Spend Plan, and any updates to that plan. Within the total for the Testing Spend Plan, HHS may update this plan by increasing or decreasing any line by the lesser of $500,000 or 5%. HHS must notify OMB within five business days of any such change by providing an updated Testing Spend Plan and supporting rationale. |
| A8 | Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. |
| A9 | Funds are available immediately for obligation consistent with the December 27, 2021 Public Health Workforce spend plan. Funds are available for additional projects five business days after an HHS approved spend plan has been submitted to OMB. |
| B1 | Amount on line 1134 has been adjusted pursuant to OMB Bulletin 21-05. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A10 | Funds are available for obligation from lines 6038, 6039, and 6046 consistent with the September 20, 2021 spend plan. $8,890,184,575 is available for obligation five business days after HHS submits to OMB a detailed allocation methodology for any new funding allocation. In addition, the amount available for immediate obligation shall be increased by the amount of recoveries of prior year HRSA Provider Relief Fund obligations consistent with the aggregate limitations by line items in the September 20, 2021 Provider Relief Spend Plan. HHS will regularly update OMB on these recoveries. Detailed obligation amounts will be submitted to OMB after FY 2021 actuals are available. |
| A11 | For amounts appropriated in P.L. 116-260 that appear in this Category B line, funds are available immediately for obligation consistent with the FY 2021 spend plan submitted to OMB, and any updates to that plan. HHS will notify OMB in writing five business days in advance of any deviations to the HHS and OMB reviewed spend plan activity amounts that are greater than ten percent. |
| A12 | HHS will inform OMB in writing three business days in advance of any deviations from ASPR's activities or funding in HHS' most recent Congressional spend plan provided as required in Public Laws 116-127 and 116-139. |
| A13 | Funds are available immediately for obligation consistent with the September 3, 2021, Section 2401 Testing Spend Plan. Funds are available for additional activities five business days after HHS provides OMB notification of spending plans. |
| A14 | Funds are available immediately for obligation consistent with the September 30, 2021 FY 22 Operation Spending Plan. HHS will promptly notify OMB of changes by the lesser of $10,000,000 or 10 percent in the cost of those contracts, IAAs, and IDDAs. Funds are available for additional projects five business days after HHS provides OMB notification of spending plans. |
| A2 | Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments. |
| A3 | The multiple category B lines for Pandemic Influenza are used because some appropriations had more broad legal authorities than others. Obligations may be funded from multiple category B lines provided that the obligation is consistent with the purpose of the appropriation. |
| A4 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available, plus the amount governed by footnote A10. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A5 | Lines 6038 (P.L 116-136), 6039 (P.L. 116-139), and 6046 (P.L. 116-260) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. |
| A6 | Lines 6037 (P.L. 116-127) and 6042 (P.L. 116-139) are for the same legal purposes, but are segregated solely for reporting purposes, and not for purposes of enforcement of the Antideficiency Act. |
| A7 | Funds are available immediately for obligation consistent with the July 21, 2021 PPPHCEA Testing Spend Plan, and any updates to that plan. Within the total for the Testing Spend Plan, HHS may update this plan by increasing or decreasing any line by the lesser of $500,000 or 5%. HHS must notify OMB within five business days of any such change by providing an updated Testing Spend Plan and supporting rationale. |
| A8 | Funds are available for obligation five business days after an HHS-approved spend plan has been submitted to OMB. |
| A9 | Of this total, $740,755,785 is available immediately for obligation consistent with the previously approved Public Health Workforce FY 2021 spend plan. Funds are available for additional projects five business days after an HHS approved spend plan has been submitted to OMB. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.